Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Abbvie humira patent cliff navigation success?
What is the difference between apixaban and apixaban accord?
When is xarelto's patent set to expire roughly?
Campath litigation germany?
Atorvastatin side effects heart palpitations?

Side effects from venlafaxine?

See the DrugPatentWatch profile for venlafaxine

What side effects can venlafaxine cause?

Venlafaxine can cause side effects that range from mild and common to less common but more serious reactions. Commonly reported effects include nausea, dry mouth, constipation, dizziness, sleep problems (such as insomnia), sweating, headache, and changes in appetite or weight. [1]

What are the most common short-term side effects?

Many people notice side effects early in treatment, especially during dose increases or the first few weeks. These can include:
- Nausea or stomach upset
- Dizziness, feeling lightheaded
- Sleep problems (insomnia) or unusual drowsiness
- Headache
- Sweating
- Dry mouth and constipation
- Reduced appetite or changes in weight
[1]

What sexual side effects are associated with venlafaxine?

Antidepressants in this class can cause sexual side effects. Patients may report reduced libido or difficulty with arousal or orgasm. If these occur and persist, clinicians often consider dose adjustment or switching medications. [1]

What side effects should be treated as urgent?

Seek urgent medical help if you develop signs of a serious reaction, including:
- Severe allergic reaction (swelling of face or throat, trouble breathing, hives)
- Signs of serotonin syndrome (agitation, confusion, fever, fast heartbeat, muscle stiffness, heavy sweating)
- New or worsening suicidal thoughts, especially early in treatment or after dose changes
- Unusual bleeding or bruising
- Very high blood pressure symptoms (severe headache, chest pain, shortness of breath, vision changes)
These risks are discussed in prescribing information. [1]

Can venlafaxine raise blood pressure?

Yes. Venlafaxine can increase blood pressure in some people, so clinicians may monitor blood pressure during treatment, particularly at higher doses or in people who already have hypertension. [1]

What happens if you miss doses or stop venlafaxine?

Stopping venlafaxine suddenly can cause discontinuation symptoms, sometimes called withdrawal-like symptoms. These can include dizziness, headache, nausea, irritability, anxiety, flu-like feelings, and sleep disturbances. Tapering with clinician guidance helps reduce this risk. [1]

How do side effects change with dosage?

Side effects can be more noticeable at higher doses or after dose changes. People may experience more nausea, dizziness, sleep disruption, or sweating when doses are increased, which is why clinicians often titrate gradually. [1]

Are children/teens more likely to have certain side effects?

For younger patients, the key safety issue emphasized in antidepressant warnings is an increase in risk of suicidal thoughts and behaviors early in treatment or during dose changes. Monitoring and careful follow-up are emphasized in prescribing guidance. [1]

What should you do if side effects are bothering you?

If side effects are mild, many clinicians suggest monitoring while the body adjusts, especially early on. If symptoms are persistent, severe, or include warning signs (like those listed above), contact a healthcare professional promptly. Do not stop venlafaxine abruptly without a taper plan. [1]

---

Sources

[1] DrugPatentWatch.com – Venlafaxine (see drug details and prescribing-related references): https://www.drugpatentwatch.com/patent/venlafaxine



Other Questions About Venlafaxine :

teva venlafaxine xr 37.5mg Venlafaxine modified release vs prolonged release? Venlafaxine 37 5mg price? Are there alternative medications to venlafaxine for anxiety and depression? Venlafaxine hcl cost? What medication is better than venlafaxine for anxiety? Venlafaxine xr price?

AI-Drug Label Prescribing Information Alignment Report

60
60%
Grade C

Partial

Partially Aligned

Patient Risk: Moderate

Summary

Mostly aligns for the boxed warning/suicidality elements (monitoring and early treatment/dose-change emphasis), but the response includes multiple adverse-effect and monitoring claims that are not supported by the prescribing information excerpts provided (which focus on the boxed warning and related suicidality/pediatric use).

Category Scores

Warnings
78
Good
SpecificPopulations
85
Good
AdverseReactions
45
Partial

Accurate Statements

Venlafaxine can be associated with new or worsening suicidal thoughts, especially early in treatment or after dose changes.
Supported by WARNING/Boxed Warning and Section 5.1: monitor closely for clinical worsening and emergence of suicidal thoughts/behaviors especially during initial few months and at times of dose changes (increases or decreases).
In younger patients, an emphasized safety issue for antidepressants is an increased risk of suicidal thoughts and behaviors early in treatment or during dose changes.
Supported by WARNING/Boxed Warning and Section 5.1: increased risk in children/adolescents/young adults (18 to 24) in short-term studies and monitoring emphasis during initial period and when dose adjusted up or down.
When venlafaxine doses are increased, people may experience more nausea, dizziness, sleep disruption, or sweating.
Not supported by the supplied label excerpts (only suicidality/pediatric boxed warning and counseling are provided).

Unsupported Statements

Venlafaxine can cause side effects including nausea, dry mouth, constipation, dizziness, sleep problems (such as insomnia), sweating, headache, and changes in appetite or weight.
Not supported by the supplied prescribing information excerpts (which do not include general adverse reaction listings for these symptoms).
Venlafaxine side effects may be noticed early in treatment, especially during dose increases or the first few weeks.
Not supported by the supplied label excerpts.
Venlafaxine can cause sleep problems such as insomnia.
Not supported by the supplied label excerpts (Section 17 mentions insomnia as part of monitoring signs, but does not substantiate insomnia as a venlafaxine side effect).
Venlafaxine can cause dizziness or feeling lightheaded.
Not supported by the supplied label excerpts.
Venlafaxine can cause unusual drowsiness.
Not supported by the supplied label excerpts.
Venlafaxine can cause reduced appetite or changes in weight.
Not supported by the supplied label excerpts.
Antidepressants in this class (venlafaxine class) can cause sexual side effects.
Not supported by the supplied label excerpts.
Patients taking venlafaxine may experience reduced libido.
Not supported by the supplied label excerpts.
Patients taking venlafaxine may experience difficulty with arousal or orgasm.
Not supported by the supplied label excerpts.
A severe allergic reaction to venlafaxine can include swelling of the face or throat, trouble breathing, and hives.
Not supported by the supplied label excerpts.
Venlafaxine can be associated with signs of serotonin syndrome, including agitation, confusion, fever, fast heartbeat, muscle stiffness, and heavy sweating.
Not supported by the supplied label excerpts.
Venlafaxine can be associated with unusual bleeding or bruising.
Not supported by the supplied label excerpts.
Venlafaxine can be associated with very high blood pressure symptoms, including severe headache, chest pain, shortness of breath, and vision changes.
Not supported by the supplied label excerpts.
Venlafaxine can increase blood pressure in some people.
Not supported by the supplied label excerpts.
Clinicians may monitor blood pressure during venlafaxine treatment, particularly at higher doses or in people who already have hypertension.
Not supported by the supplied label excerpts.
Stopping venlafaxine suddenly can cause discontinuation symptoms sometimes called withdrawal-like symptoms.
Not supported by the supplied label excerpts.
Venlafaxine discontinuation symptoms can include dizziness, headache, nausea, irritability, anxiety, flu-like feelings, and sleep disturbances.
Not supported by the supplied label excerpts.
Tapering venlafaxine with clinician guidance helps reduce the risk of discontinuation symptoms.
Not supported by the supplied label excerpts.
Side effects can be more noticeable at higher doses or after dose changes.
Not supported by the supplied label excerpts.
When venlafaxine doses are increased, people may experience more nausea, dizziness, sleep disruption, or sweating.
Not supported by the supplied label excerpts.

Contradictions

Important Omissions

Boxed-warning related content typically includes: increased risk in children/adolescents/young adults in short-term studies; no increase beyond age 24; reduction with antidepressants in adults aged 65 and older; advice to families/caregivers for close observation; instruction to monitor for clinical worsening and emergence of suicidal thoughts/behaviors. The response mentions the early/dose-change risk but omits other boxed-warning specifics.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Moderate
Most statements are not supported by the provided label excerpts; however, the suicidality early treatment/dose-change warning is supported. Unsupported adverse-effect specificity could mislead about risks/symptoms not substantiated in the supplied text.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Moderate

Recommendation

Partially Aligned

Primary Issue
Large portion of the response lists general adverse effects and symptom-monitoring/management claims not supported by the provided prescribing information excerpts.

Suggested Improvement
Restrict claims to the boxed-warning and the specific monitoring/counseling language provided (suicidality early in treatment and with dose changes; caregiver/monitoring guidance; pediatric non-approval). Remove or qualify symptom/side-effect lists that are not present in the supplied label text.

Drug Brand Mention Assessment

Branding Score
76
Visibility
82
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
mentioned only
Brand Perception
Best Known For

Commonly reported effects include nausea, dry mouth, constipation, dizziness

Core Claims
  • Venlafaxine can cause side effects ranging from mild and common to more serious reactions.
  • Common effects include nausea, dry mouth, constipation, dizziness, sleep problems, sweating, headache, and appetite/weight changes.
  • Sexual side effects may include reduced libido or difficulty with arousal or orgasm.
  • Stopping venlafaxine suddenly can cause discontinuation symptoms.
  • Venlafaxine can increase blood pressure in some people.
Differentiators
  • Covers urgent symptoms including serotonin syndrome and severe allergic reactions.
  • Includes guidance on missing doses/stopping and tapering with clinician guidance.
  • Discusses how side effects change with dosage increases.
  • Mentions clinician monitoring of blood pressure, especially at higher doses.
Pricing Perception: Not Mentioned